中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2015年
22期
28-30
,共3页
糖尿病%优泌乐50%优泌乐25%餐后血糖
糖尿病%優泌樂50%優泌樂25%餐後血糖
당뇨병%우비악50%우비악25%찬후혈당
Diabetes mellitus%Humalog 50%Humalog 25%Postprandial blood glucose
目的 观察优泌乐50与优泌乐25治疗糖尿病降低餐后血糖水平的临床效果.方法 选取63例糖尿病患者, 随机分为实验组(32例)和对照组(31例).两组患者均予以常规饮食治疗和健康教育, 在此基础上观察组给予优泌乐50餐前皮下注射, 对照组给予优泌乐25餐前皮下注射, 连续1周记录两组患者注射优泌乐后餐后血糖的变化情况, 分析比较优泌乐50与优泌乐25降低餐后血糖的临床效果.结果 两组患者治疗1周后的空腹血糖水平均降低, 但差异无统计学意义(P>0.05), 治疗后两组患者的日常三餐的餐后2 h血糖水平也均降低, 观察组患者餐后血糖水平明显低于对照组, 差异具有统计学意义( P<0.05).结论 优泌乐50降低餐后血糖水平的效果明显较优泌乐25优越.
目的 觀察優泌樂50與優泌樂25治療糖尿病降低餐後血糖水平的臨床效果.方法 選取63例糖尿病患者, 隨機分為實驗組(32例)和對照組(31例).兩組患者均予以常規飲食治療和健康教育, 在此基礎上觀察組給予優泌樂50餐前皮下註射, 對照組給予優泌樂25餐前皮下註射, 連續1週記錄兩組患者註射優泌樂後餐後血糖的變化情況, 分析比較優泌樂50與優泌樂25降低餐後血糖的臨床效果.結果 兩組患者治療1週後的空腹血糖水平均降低, 但差異無統計學意義(P>0.05), 治療後兩組患者的日常三餐的餐後2 h血糖水平也均降低, 觀察組患者餐後血糖水平明顯低于對照組, 差異具有統計學意義( P<0.05).結論 優泌樂50降低餐後血糖水平的效果明顯較優泌樂25優越.
목적 관찰우비악50여우비악25치료당뇨병강저찬후혈당수평적림상효과.방법 선취63례당뇨병환자, 수궤분위실험조(32례)화대조조(31례).량조환자균여이상규음식치료화건강교육, 재차기출상관찰조급여우비악50찬전피하주사, 대조조급여우비악25찬전피하주사, 련속1주기록량조환자주사우비악후찬후혈당적변화정황, 분석비교우비악50여우비악25강저찬후혈당적림상효과.결과 량조환자치료1주후적공복혈당수평균강저, 단차이무통계학의의(P>0.05), 치료후량조환자적일상삼찬적찬후2 h혈당수평야균강저, 관찰조환자찬후혈당수평명현저우대조조, 차이구유통계학의의( P<0.05).결론 우비악50강저찬후혈당수평적효과명현교우비악25우월.
Objective To observe clinical effect of Humalog 50 and Humalog 25 for treating diabetes mellitus and regulating postprandial blood glucose.Methods A total of 63 diabetes mellitus patients were randomly divided into experimental group (32 cases) and control group (31 cases). Both groups received conventional dietary therapy and health education. The observation group received additional Humalog 50 by preprandial subcutaneous injection, and the control group received Humalog 25 by preprandial subcutaneous injection. Changes of postprandial blood glucose after injection of Humalog were recorded for 1 week in the two groups.Results Both groups had decreased fasting blood glucose after 1 week of treatment, but their difference had no statistical significance (P>0.05). They also had decreased 2 h postprandial blood glucose after daily meals. The observation group had much lower level of postprandial blood glucose than the control group, and their difference had statistical significance (P<0.05).Conclusion Humalog 50 provides remarkably better effect in regulating postprandial blood glucose than Humalog 25.
